ENTITY
CSL Ltd

CSL Ltd (CSL AU)

172
Analysis
Health CareAustralia
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
19 Oct 2019 10:51

Aussie Equities Model Portfolio Update (October): Sticking to the Knitting

Our model portfolio has added 200bp of Alpha since our last update and our stock selection remains broadly unchanged.  However, we make some key...

Logo
468 Views
Share
30 Sep 2019 07:47

Developed Markets Opportunities

Continue to favor EAFE over EM. As long as the U.S. dollar remains elevated, we believe  developed international (EAFE) will remain in a leadership...

Logo
660 Views
Share
20 Sep 2019 11:25

The Deadcat Bounce in Aussie Value

The Global rotation away from Defensive stocks to cyclical Growth and Value over the past few weeks has not been impressive enough to convince us...

Logo
796 Views
Share
20 Sep 2019 03:06

China Biologic's Privatisation Redux

On Wednesday after market close, China Biologic Products (CBPO US) announced a surprising privatisation bid from a consortium for $120 per ADS. The...

Logo
876 Views
Share
16 Sep 2019 17:44

Ramsay Health Care A$1.3bn Placement - A Decent Stock but Past Performance Weighs

Ramsay Health Care's largest shareholder, Paul Ramsay Foundation, is selling AUD 1.3 billion block after market close today. In this insight, we...

Logo
835 Views
Share
x